First approval for production of an anti-HIV antibody in plants

UK regulators have approved Europe’s first clinical trial of an antibody produced from genetically modified (GM) plants. Taking place at the University of Surrey, this is the result of a landmark decision setting the stage for the testing in humans of an anti-HIV product made from modified tob..